Why the study?
Does non-invasive peripheral arterial tonometry predict late cardiovascular adverse events?
Does non-invasive peripheral arterial tonometry predict late cardiovascular adverse events?
Non-invasive assessment of peripheral vascular function using EndoPAT may help identify patients at risk for late cardiovascular adverse events.
A low RH signal detected by EndoPAT, consistent with endothelial dysfunction, was associated with higher AE rate during follow-up. L_RHI was an independent predictor of AE. Non-invasive assessment of peripheral vascular function may be useful for the identification of patients at risk for cardiac AEs.
No takes yet. Share an insight, caveat, or question.
Rubinshtein et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: